DERMAPHARM HLDG INH O.N./ DE000A2GS5D8 /
13/06/2024 21:45:07 | Var. -0.600 | Volume | Denaro22:00:02 | Lettera22:00:02 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
36.350EUR | -1.62% | 0 Fatturato: 0.000 |
-Quantità in denaro: - | -Quantità in lettera: - | 2 bill.EUR | 2.37% | 32.07 |
GlobeNewswire
00:59
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Charge Enterprises, Inc. Investors to Secure Couns...
GlobeNewswire
00:58
Contact Hagens Berman by August 6, 2024 Deadline to Join Class Action Against FAT Brands (FAT, FATBB...
GlobeNewswire
00:57
Malibu Boats (MBUU) Under Fire After Securities Class Action Filed – Hagens Berman
GlobeNewswire
00:45
Equinix (EQIX) Financials Under Scrutiny as Short Seller Dispute Intensifies - Hagens Berman June 1...
GlobeNewswire
00:43
Autodesk (ADSK) Accounting Probe Finds Manipulation of Financial Metrics– Hagens Berman
GlobeNewswire
00:22
Reno and TMWA Awarded $30 Million Federal “WaterSMART” Grant for Advanced Purified Water Facility
GlobeNewswire
00:22
AKRO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Akero Therapeutics, Inc. Invest...
GlobeNewswire
13/06
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Roblox Corporation Investors to Secure Counsel Before I...
Newsfile Corp
13/06
GDRX DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secur...